SUPPRESSION OF MALIGNANT PHENOTYPE IN A HUMAN PROSTATE-CANCER CELL-LINE BY FRAGMENTS OF NORMAL CHROMOSOMAL REGION 17Q

被引:0
|
作者
MURAKAMI, YS
BROTHMAN, AR
LEACH, RJ
WHITE, RL
机构
[1] UNIV UTAH,HLTH SCI CTR,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112
[2] UNIV UTAH,DEPT HUMAN GENET,SALT LAKE CITY,UT 84112
[3] UNIV UTAH,DEPT PEDIAT,SALT LAKE CITY,UT 84112
[4] UNIV TEXAS,HLTH SCI CTR,DEPT CELLULAR & STRUCT BIOL,SAN ANTONIO,TX 78284
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recent evidence obtained by in situ hybridization indicates that chromosomal region 17q is often lost in prostate tumors, To substantiate the presence of tumor suppressor genes in this chromosomal region, normal human 17q tagged with a neomycin resistance gene was transferred into a human prostate cancer cell line, PPC-I, by microcell-mediated chromosome transfer, Two hybrid clones were obtained, both of which shelved decreased tumorigenicity in athymic nude mice and decreased efficiency of colony formation in soft agar with respect to PPC-1. When microcells were irradiated prior to transfer of chromosomal region 17q to determine which subchromosomal regions carry the potential tumor suppressor gene(s), 10 hybrid clones were obtained, including 6 fully malignant and 4 suppressed clones, Analysis of polymorphic loci on 17q in the series of hybrid clones suggested that a tumor suppressor gene associated with prostate cancer was located in a region no more than 28 cM long at 17q12-q22, which includes the BRCA1 gene involved in hereditary breast cancer.
引用
收藏
页码:3389 / 3394
页数:6
相关论文
共 50 条
  • [41] THE SYNTHETIC ANDROGEN MIBOLERONE INDUCES TRANSIENT SUPPRESSION OF THE TRANSFORMED PHENOTYPE IN AN ANDROGEN RESPONSIVE HUMAN PROSTATIC-CARCINOMA CELL-LINE
    SCHULZ, P
    WOLF, D
    ARBUSOW, V
    BOJAR, H
    KLOBECK, HG
    FITTLER, F
    ANDROLOGIA, 1990, 22 : 56 - 66
  • [42] EFFECT OF ETIDRONATE DISODIUM ON THE DEVELOPMENT OF BONE-LESIONS IN AN ANIMAL-MODEL OF BONE METASTASIS USING THE HUMAN PROSTATE-CANCER CELL-LINE PC-3
    SHEVRIN, DH
    GORNY, KI
    ROSOL, TJ
    KUKREJA, SC
    PROSTATE, 1991, 19 (02): : 149 - 154
  • [43] ANDROGENIC AND ANTIANDROGENIC CONTROL ON EPIDERMAL GROWTH-FACTOR, EPIDERMAL GROWTH-FACTOR RECEPTOR, AND ANDROGEN RECEPTOR EXPRESSION IN HUMAN PROSTATE-CANCER CELL-LINE LNCAP
    RAVENNA, L
    LUBRANO, C
    DISILVERIO, F
    VACCA, A
    FELLI, MP
    MARODER, M
    DERAMO, G
    SCIARRA, F
    FRATI, L
    GULINO, A
    PETRANGELI, E
    PROSTATE, 1995, 26 (06): : 290 - 298
  • [44] INHIBITION OF GROWTH AND INDUCTION OF DIFFERENTIATION IN A MALIGNANT HUMAN GLIOMA CELL-LINE BY NORMAL LEPTOMENINGEAL EXTRACELLULAR-MATRIX PROTEINS
    RUTKA, JT
    GIBLIN, JR
    APODACA, G
    DEARMOND, SJ
    STERN, R
    ROSENBLUM, ML
    CANCER RESEARCH, 1987, 47 (13) : 3515 - 3522
  • [45] Use of an anti-ras ribozyme to alter the malignant phenotype of a human bladder cancer cell line
    Eastham, JA
    Ahlering, TE
    JOURNAL OF UROLOGY, 1996, 156 (03): : 1186 - 1188
  • [46] ELECTROPHYSIOLOGICAL CHARACTERIZATION OF A TTX-SENSITIVE NA+ CURRENT IN THE HIGHLY METASTATIC MAT-LYLU RAT PROSTATE-CANCER CELL-LINE
    GRIMES, JA
    DJAMGOZ, MBA
    JOURNAL OF PHYSIOLOGY-LONDON, 1995, 489P : P50 - P50
  • [47] ANDROGEN-INDUCED INHIBITION OF CELL-PROLIFERATION IN AN ANDROGEN-INSENSITIVE PROSTATE-CANCER CELL-LINE (PC-3) TRANSFECTED WITH A HUMAN ANDROGEN RECEPTOR COMPLEMENTARY-DNA
    YUAN, SX
    TRACHTENBERG, J
    MILLS, GB
    BROWN, TJ
    XU, F
    KEATING, A
    CANCER RESEARCH, 1993, 53 (06) : 1304 - 1311
  • [48] EFFECT OF 5-ALPHA-REDUCTASE INHIBITION AND DEXAMETHASONE ADMINISTRATION ON THE GROWTH-CHARACTERISTICS AND INTRATUMOR ANDROGEN LEVELS OF THE HUMAN PROSTATE-CANCER CELL-LINE PC-3
    TUTTLE, RM
    LOOP, S
    JONES, RE
    MEIKLE, AW
    OSTENSON, RC
    PLYMATE, SR
    PROSTATE, 1994, 24 (05): : 229 - 236
  • [49] Stepwise genetic changes associated with progression of nontumorigenic HPV-18 immortalized human prostate cancer-derived cell line to a malignant phenotype
    Hukku, B
    Mally, M
    Cher, ML
    Peehl, DM
    Kung, HF
    Rhim, JS
    CANCER GENETICS AND CYTOGENETICS, 2000, 120 (02) : 117 - 126
  • [50] DRUG-INDUCED APOPTOSIS IS NOT NECESSARILY DEPENDENT ON MACROMOLECULAR-SYNTHESIS OR PROLIFERATION IN THE P53-NEGATIVE HUMAN PROSTATE-CANCER CELL-LINE PC-3
    BORNER, MM
    MYERS, CE
    SARTOR, O
    SEI, Y
    TOKO, T
    TREPEL, JB
    SCHNEIDER, E
    CANCER RESEARCH, 1995, 55 (10) : 2122 - 2128